Cell Therapy Management Program (CTMP)

Por Márquez, J.L., Imbernón, J., Pérez-Calvo, J., Rifón, J., García-Foncillas, J.
Publicado em 2001

Development of a Windows Version of a General Modelling Program with Bayesian Fitting for Individualized Therapy of Patients

Por Imbernon, Negrillo, J., Marquez, J.L., Aldaz, A., Jelliffe, R., Garcia-Foncillas, J.
Publicado em 2001

Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated withchemo-radiotherapy

Por R, RN Zárate, Arias, F, Bandres, E, Cubedo, E, Malumbres, R, García-Foncillas, J
Publicado em 2006

Combining chemotherapy and targeted therapies in metastatic colorectal cancer

Por Rodriguez, J, Zarate, R, Bandres, E, Viudez, A, Chopitea, A, García-Foncillas, J, Gil-Bazo, I
Publicado em 2007

Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What’s new?

Por Ponz-Sarvisé, M, Rodríguez, J, Viudez, A, Chopitea, A, Calvo, A, García-Foncillas, J, Gil-Bazo, I
Publicado em 2007

Comment on ‘TAp63 suppress metastasis via miR-133b in colon cancer cells'

Por Cristobal, I, Madoz-Gurpide, J, Martin-Aparicio, E, Carames, C, Aguilera, O, Rojo, F, Garcia-Foncillas, J
Publicado no Br J Cancer (2014)

Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review

Por García-Foncillas, J, Alba, E, Aranda, E, Díaz-Rubio, E, López-López, R, Tabernero, J, Vivancos, A
Publicado no Ann Oncol (2017)

Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients

Por Abajo, A, Rodriguez, J, Bitarte, N, Zarate, R, Boni, V, Ponz, M, Chopitea, A, Bandres, E, Garcia-Foncillas, J
Publicado em 2010

Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?

Por Gil-Bazo, I., González, J. A Díaz, Rodríguez, J., Cortés, J., Calvo, E., Páramo, J. A., García-Foncillas, J.
Publicado no World J Gastroenterol (2005)

Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients

Por Abajo, A, Boni, V, Lopez, I, Gonzalez-Huarriz, M, Bitarte, N, Rodriguez, J, Zarate, R, Bandres, E, Garcia-Foncillas, J
Publicado em 2012

Phosphorylated protein phosphatase 2A determines poor outcome in patients with metastatic colorectal cancer

Por Cristóbal, I, Manso, R, Rincón, R, Caramés, C, Zazo, S, del Pulgar, T G, Cebrián, A, Madoz-Gúrpide, J, Rojo, F, García-Foncillas, J
Publicado em 2014

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

Por Bandrés, E, Cubedo, E, Agirre, X, Malumbres, R, Zárate, R, Ramirez, N, Abajo, A, Navarro, A, Moreno, I, Monzó, M, García-Foncillas, J
Publicado em 2006

Clinical guideline SEOM: hepatocellular carcinoma

Por Sastre, J., Díaz-Beveridge, R., García-Foncillas, J., Guardeño, R., López, C., Pazo, R., Rodriguez-Salas, N., Salgado, M., Salud, A., Feliu, J.
Publicado no Clin Transl Oncol (2015)

Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts

Por Camps Herrero C, Antón Torres A, Cruz-Hernández JJ, Carrato A, Constenla M, Díaz-Rubio E, Feyjoo Saus M, Garcia-Foncillas J, Gascón P, Guillem V
Publicado em 2019-07-01

Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

Por Cortes, J, Rodriguez, J, Diaz-Gonzalez, J A, Garzon, C, Gurpide, A, Arbea, L, Gil-Bazo, I, Navarro, V, Cambeiro, M, Nicolas, A I, Martin-Algarra, S, Garcia-Foncillas, J, Calvo, E
Publicado em 2002

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

Por Martinez-Useros, J., Moreno, I., Fernandez-Aceñero, M. J., Rodriguez-Remirez, M., Borrero-Palacios, A., Cebrian, A., Gomez del Pulgar, T., del Puerto-Nevado, L., Li, W., Puime-Otin, A., Perez, N., Soengas, M. S., Garcia-Foncillas, J.
Publicado no BMC Cancer (2018)

Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6α and p-p38 “STARD Compliant”

Por Martinez-Useros, J., Georgiev-Hristov, T., Borrero-Palacios, A., Fernandez-Aceñero, M.J., Rodríguez-Remírez, M., del Puerto-Nevado, L., Cebrian, A., Gomez del Pulgar, M.T., Cazorla, A., Vega-Bravo, R., Perez, N., Celdran, A., Garcia-Foncillas, J.
Publicado no Medicine (Baltimore) (2015)

Active angiogenesis in metastatic renal cell carcinoma predicts clinical benefit to sunitinib-based therapy

Por del Puerto-Nevado, L, Rojo, F, Zazo, S, Caramés, C, Rubio, G, Vega, R, Chamizo, C, Casado, V, Martínez-Useros, J, Rincón, R, Rodríguez-Remírez, M, Borrero-Palacios, A, Cristóbal, I, Madoz-Gúrpide, J, Aguilera, O, García-Foncillas, J
Publicado em 2014